---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-045154"
form_type: "8-K"
ticker: "FHTX"
cik: "0001822462"
company_name: "Foghorn Therapeutics Inc."
filed_at: "2026-06-24T20:01:11+00:00"
generated_at: "2026-06-24T20:02:20.875702+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Foghorn Therapeutics reports 2026 annual meeting voting results; all proposals pass

## Summary
- Director nominees elected: Cole (35.1M for, 11.0M against), Gill (46.0M for), Parshall (44.4M for).
- Ratification of Deloitte & Touche as auditor for FY2026 approved with 51.7M votes for.
- Advisory vote on executive compensation approved with 45.6M for vs 0.5M against.
- Stockholders recommended 1-year frequency for future say-on-pay votes (45.6M for one year).

## SEC filing metadata
- accession: 0001628280-26-045154
- form_type: 8-K
- ticker: FHTX
- cik: 0001822462
- company_name: Foghorn Therapeutics Inc.
- filed_at: 2026-06-24T20:01:11+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822462/000162828026045154/0001628280-26-045154-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822462/000162828026045154/fhtx-20260624.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-045154
- JSON: https://secwatch.observer/filing/0001628280-26-045154.json
- Plain text: https://secwatch.observer/filing/0001628280-26-045154.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.